In the June issue of Diagnostic Imaging, we noted with approval the decision by the Society for Computer Applications in Radiology to change its name to the Society for Imaging Informatics in Medicine.
In the June issue of Diagnostic Imaging, we noted with approval the decision by the Society for Computer Applications in Radiology to change its name to the Society for Imaging Informatics in Medicine.
The imaging informatics picture is growing broader-encompassing more types of medical information, more specialists, and more parts of the medical enterprise-so it was appropriate that SCAR shift its name to the perhaps more sibilant SIIM.
The same rationale underlies our shift in the name of our PACS and Informatics supplement, now 10 years old, to Enterprise Imaging & IT. Over the years, we've watched as digital radiological images have moved further into the healthcare enterprise to become an ever more important part of the medical decision-making process. This diffusion has entailed some shifts in strategy and focus for radiologists and others involved in the digital management of images.
Our purpose in making this name change is to recognize these adjustments and make sure our coverage remains topical and closely tied to the realities of digital imaging practice.
We believe our readers are closely interested in imaging informatics, but imaging informatics now extends throughout the enterprise. Our readers' focus is expanding, and ours will as well.
-John C. Hayes is editor of Diagnostic Imaging
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.